Allergan talks taxes and competition in 2018 outlook
Allergan (NYSE:AGN) had a busy, and occasionally fraught, 2017. After the company inked a controversial deal with a Native American tribe to shield its Restasis patents from review, a federal judge in Texas invalidated the IP, helping to clear the way for generics. And just last week, Allergan announced that it would slash 1,400 jobs in an effort to cut costs. But looking ahead to the new year, chairman and chief executive Brent Saunders seems optimistic. Get the full story at our sister site, Drug Delivery Business News. The post Allergan talks taxes and competition in 2018 outlook appeared first on MassDevice.
Publication date: Available online 4 April 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Priya Bansal, Theresa A. Bingemann, Matthew Greenhawt, Giselle Mosnaim, Anil Nanda, John Oppenheimer, Hemant Sharma, David Stukus, Marcus Shaker
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, says the U.S. is "struggling" to get the spread of coronavirus under control.
The head of the National Institute of Allergy and Infectious Diseases has become the face of the nation's pandemic response. Lee Cowan talks about how Dr. Anthony Fauci, the most-trusted voice in the administration's efforts to stem the spread of the coronavirus, has earned plenty of admirers — and some good-natured displays of appreciation.
The director of the National Institute of Allergy and Infectious Diseases spoke with The New England Journal of Medicine in a podcast about how physicians can approach talking to patients regarding COVID-19.
AbstractAllergic diseases are on the increase and can affect the child ’s well-being. The aim of this survey was to assess regional schools’ preparedness in dealing with anaphylaxis following the publication of national and international guidelines for schools in 2014. The survey was developed in 2015 and distributed to schools in Cumbria, North West England, UK be tween 2015 and 2016. Only 47% of the respondents (95% CI, 39–57%) felt confident to manage anaphylaxis. Schools without allergic pupils were significantly less likely to have a standard management protocol in place for emergencies compared to&n...
Publication date: Available online 12 March 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Karsten Weller, Tamara Donoso, Markus Magerl, Emel Aygören-Pürsün, Petra Staubach, Inmaculada Martinez-Saguer, Tomasz Hawro, Sabine Altrichter, Karoline Krause, Frank Siebenhaar, Martin Metz, Torsten Zuberbier, Denise Freier, Marcus Maurer
The agency granted the authorization to global biopharacuetical company Cellex. Of 128 samples confirmed positive by RT-PCR in premarket testing, 120 tested positive by IgG, IgM, or both.FDA Approvals
Publication date: 4 April 2020Source: New Scientist, Volume 245, Issue 3276Author(s): Gege Li
A consistent increase in the intensity and length of allergy season in regions of the United States signals a difficult season in 2020, at the same time as the COVID-19 pandemic affects communities.Medscape Medical News
‘Grandfather of allergy’ survived three years in Japanese POW camp before pioneering medical careerDr William Frankland, a pioneering British immunologist who transformed the world ’s understanding of allergies, has died aged 108.Frankland improved the lives of millions of hay fever sufferers by developing the idea of apollen count. Until his death the oldest survivor of the Japanese prisoner of war camps, he published a scientific paper in September 2017 aged 105.Continue reading...